EFFECTS OF PROBUCOL ON HOMOZYGOUS CASES OF FAMILIAL HYPERCHOLESTEROLEMIA

被引：97
作者：
YAMAMOTO, A
MATSUZAWA, Y
KISHINO, B
HAYASHI, R
HIROBE, K
KIKKAWA, T
机构：
[1] OSAKA UNIV HOSP,DEPT INTERNAL MED 2,OSAKA,JAPAN
[2] SUMITOMO HOSP,OSAKA,JAPAN
来源：
ATHEROSCLEROSIS | 1983年 / 48卷 / 02期
关键词：
D O I：
10.1016/0021-9150(83)90102-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 166
页数：10
相关论文
共 25 条
[1]  
BAKER SG, 1982, S AFR MED J, V62, P7
[2]  
Brown M S, 1975, Adv Intern Med, V20, P273
[3]  
BURSTEIN M, 1973, ADV LIPID RES, V11, P68
[4]  
ENJALBERT M, 1980, CAN MED ASSOC J, V123, P754
[5]   LDL RECEPTOR LOCUS AND THE GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA [J].
GOLDSTEIN, JL ;
BROWN, MS .
ANNUAL REVIEW OF GENETICS, 1979, 13 :259-289
[6]   LONG-TERM ORAL-ADMINISTRATION OF PROBUCOL [4,4'-(ISOPROPYLIDENEDITHIO)BIS (2,6-DI-T-BUTYLPHENOL)] (DH-581) IN MANAGEMENT OF HYPERCHOLESTEROLEMIA [J].
HARRIS, RS ;
GILMORE, HR ;
BRICKER, LA ;
KIEM, IM ;
RUBIN, E .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1974, 22 (04) :167-175
[7]   PROBUCOL - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN PATIENTS WITH HYPERCHOLESTEROLEMIA [J].
HEEL, RC ;
BROGDEN, RN ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1978, 15 (06) :409-428
[8]  
KAJIKAWA T, 1981, J JPN ATHEROSCLER SO, V9, P393
[9]   NORMALIZATION OF LOW-DENSITY-LIPOPROTEIN LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH A COMBINED DRUG REGIMEN [J].
KANE, JP ;
MALLOY, MJ ;
TUN, P ;
PHILLIPS, NR ;
FREEDMAN, DD ;
WILLIAMS, ML ;
ROWE, JS ;
HAVEL, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (05) :251-258
[10]   REGULATORY ROLE FOR HEPATIC LOW-DENSITY LIPOPROTEIN RECEPTORS INVIVO IN THE DOG [J].
KOVANEN, PT ;
BILHEIMER, DW ;
GOLDSTEIN, JL ;
JARAMILLO, JJ ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (02) :1194-1198
123